TRCT
CODX

Tower Research Capital (TRC)’s Co-Diagnostics CODX Stock Holding History

Tower Research Capital (TRC)’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-435
Closed -$2.2K – 5176
2025
Q4 		$2.2K Buy
435
+385
+770% +$4.19K ﹤0.01% 4571
2025
Q3 		$516 Buy
+50
New +$465 ﹤0.01% 4998
2025
Q2 		– Sell
-9
Closed -$84 – 5295
2025
Q1 		$84 Sell
9
-199
-96% -$3.8K ﹤0.01% 5047
2024
Q4 		$4.67K Buy
208
+45
+28% +$1.42K ﹤0.01% 4417
2024
Q3 		$6.1K Sell
163
-13
-7% -$499 ﹤0.01% 4183
2024
Q2 		$6.59K Sell
176
-21
-11% -$764 ﹤0.01% 4560
2024
Q1 		$6.62K Sell
197
-55
-22% -$1.99K ﹤0.01% 4343
2023
Q4 		$10.1K Buy
252
+159
+171% +$5.61K ﹤0.01% 4303
2023
Q3 		$2.95K Buy
93
+71
+323% +$2.68K ﹤0.01% 5081
2023
Q2 		$730 Sell
22
-332
-94% -$12.7K ﹤0.01% 5559
2023
Q1 		$16K Buy
354
+258
+269% +$20.7K ﹤0.01% 3682
2022
Q4 		$7K Sell
96
-866
-90% -$81.1K ﹤0.01% 4542
2022
Q3 		$93K Buy
+962
New +$135K ﹤0.01% 2626
2022
Q2 		– Sell
-264
Closed -$49K – 6117
2022
Q1 		$49K Sell
264
-452
-63% -$93.6K ﹤0.01% 2745
2021
Q4 		$192K Buy
716
+631
+742% +$166K ﹤0.01% 1805
2021
Q3 		$25K Buy
85
+19
+29% +$5.54K ﹤0.01% 3514
2021
Q2 		$16K Sell
66
-13
-16% -$3.34K ﹤0.01% 4073
2021
Q1 		$23K Sell
79
-198
-71% -$79K ﹤0.01% 3765
2020
Q4 		$78K Sell
277
-447
-62% -$166K ﹤0.01% 2589
2020
Q3 		$295K Buy
724
+681
+1,584% +$350K ﹤0.01% 2206
2020
Q2 		$25K Sell
43
-67
-61% -$30.6K ﹤0.01% 3556
2020
Q1 		$25K Buy
+110
New +$19.1K ﹤0.01% 1603
2018
Q2 		– Sell
-72
Closed -$5K – 3690
2018
Q1 		$5K Buy
72
+6
+9% +$458 ﹤0.01% 2692
2017
Q4 		$5K Buy
66
+55
+500% +$8.23K ﹤0.01% 2868
2017
Q3 		$2K Buy
+11
New +$1.68K ﹤0.01% 3550

Other funds holding CODX

PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Tower Research Capital (TRC)'s CODX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 435 shares — an estimated $2.2K sold.

Tower Research Capital (TRC) first reported a position in CODX in Q3 2017 and held it in 25 quarters. The position peaked at $295K in Q3 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 435 Co-Diagnostics shares in Q1 2026, an estimated $2.2K.
  • Tower Research Capital (TRC) first reported a position in Co-Diagnostics in Q3 2017 and held it in 25 quarters.
  • Tower Research Capital (TRC)'s Co-Diagnostics position peaked at $295K in Q3 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.